T lymphocytes from a patient with Shigella flexneri dysentery and postdysenteric reactive arthritis were cloned by limiting dilution with recombinant interleukin-2 and a strain of S. flexneri different from that which had infected her. Five of eight clones produced proliferated in response to the shigellae used to generate the clones. The response required irradiated syngeneic blood mononuclear cells as antigen-presenting cells. One such clone, MC12, proliferated in response to both the shigellae used to generate the clones and the infecting shigellae but not to other shigellae, Salmonella heidelberg, or control Escherichia coli. MC12 was CD3+, CD4+, CD8-, and human histocompatibility leukocyte antigen (HLA)-DR+. The proliferative response to the shigellae was blocked by antibody to HLA-DR but not by antibody to HLA-A,B,C. The response required antigen-presenting cells that shared HLA-DR antigens with the clone and appeared to be restricted by HLA-DR2. The epitope recognized by MC12 was associated with the bacterial membranes. Thus, Tlymphocyte clones that proliferate in response to some shigellae can be isolated from patients with shigellosis.
Protection from shigellosis appears to require specific antibodies against the Shigella somatic antigen (polysaccharide portion of lipopolysaccharide) and outer membrane virulence-associated proteins (12) . Little is known of the role of T lymphocytes in the regulation of these antibody responses or the capacity of T lymphocytes to respond to shigella antigens. However, reports of unusually severe shigellosis in patients with acquired immunodeficiency syndrome suggest that T lymphocytes may play an important role in host defense against these organisms (1) . To begin to understand the nature of T-cell responses induced by shigellae, we generated human T-lymphocyte clones with reactivity to Shigellaflexneri. Although clones have been generated with reactivity to a number of bacteria, including Mycobacterium leprae (11, 13) , Chlamydia trachomatis (15) , and Rickettsia typhi (3) , no previous reports have described Shigella- (4) . It detects all rearrangements into the J132 locus of the T-lymphocyte receptor f-chain gene in EcoRI digests of genomic DNA (4, 6) . J131 is a 2.6-kilobase HindIII-NsiI DNA fragment derived from a previously isolated genomic clone (4) . It detects all rearrangements into the J11 locus of the T-lymphocyte receptor P-chain gene in EcoRI digests of genomic DNA (22) . The two probes do not cross-hybridize.
Bacterial sonication. After a chilled dense suspension of killed CDI bacteria was sonicated for 1 min, unbroken cells were pelleted at 5,000 x g for 5 min, and the membrane fraction (inner plus outer membranes) was separated from the soluble fraction (cytoplasm plus periplasm) by centrifugation at 200,000 x g for 1 h as described previously (19) . The effectiveness of the separation was confirmed by assay of alkaline phosphatase activity as described previously (16 CD4+, CD8-, and HLA-DR+. More than 95% of the cells expressed CD2, CD3, CD4, and HLA-DR, whereas no cells expressed CD8. Some, but not all, cells expressed CD29 (68.1%) and CD45R (11.6%).
The proliferative response of MC12 to a panel of bacteria was examined (Table 2) . A response was observed to two S. flexneri serotype 2a strains: the one used to stimulate clonal proliferation, EDL, and the infecting one, CDI. A third S. flexneri serotype 2a strain, 6335, did not stimulate a proliferative response, nor did an S. flexneri serotype lb strain, 6115. MC12 did not proliferate in response to other gramnegative enteric bacteria, including S. sonnei 7061, a Salmonella heidelberg strain, or E. coli DHP1 or RR1. The proliferative response to bacteria required the presence of irradiated PBM as antigen-presenting cells. An EBV-transformed B-lymphoblastoid line generated from donor X could not substitute for PBM as antigen-presenting cells (Table 3) .
The response of MC12 to bacteria added over a 32-fold range of final concentrations (1.25 through 40 KU) was tested. CDI and EDL induced maximum responses at a concentration of 5 KU. In no case did a bacterium that failed to stimulate a response at a 5-KU concentration stimulate a response at any other concentration tested (data not shown).
The monoclonality of MC12 was defined by examining the rearrangement patterns of the T-lymphocyte receptor Pchain genes. Because of the presence of two P-chain genes, a T-lymphocyte clone can contain no more than two DNA rearrangements in either the J,1 or the J,2 gene segment cluster (6 (Table 5) . PBM from two donors who share HLA-DR2 with donor X were able to present CDI to clone MC12. PBM from HLA-DR3, -DQ2, -A32, -Ai, -B8, and -B27-positive donors could not present CDI. Thus, the antigen recognition of clone MC12 appeared to be restricted by HLA-DR2.
The location of the bacterial epitope to which MC12 responds was examined. Heat-killed CDI cells were soni- a Experiments were performed as described in Table 2 , footnote a.
b BLCL, EBV-transformed B-lymphoblastoid cell line derived from donor X. responded to an epitope on the somatic antigen (polysaccharesponse to the ride portion of LPS), which determines the serotypes of recognized an shigellae (18) . Any of a large number of other membraneraction (Fig. 2) . associated proteins, including the virulence-associated outer membrane proteins, which are important targets for protective antibodies, might bear the epitope recognized by MC12.
blishment of TThe data in Table 5 It is possible, however, that an EBV-transformed B-cell fine that is specific for S. flexneri antigens is a more effective antigen-presenting cell for S. flexneri-reactive T lymphocytes (17) .
In conclusion, we have demonstrated that Shigella-reactive T-lymphocyte clones can be generated from a patient with shigellosis. One such clone recognized some, but not all, S.flexneri strains and did not recognize closely related S.
sonnei and E. coli. The epitope recognized by this clone is associated with bacterial membranes. Analysis of Shigellareactive clones may increase our understanding of the role of T cells in the generation of a protective antibody response and perhaps lead to better strategies for vaccination against shigellosis.
